The CADEUS study: Burden of nonsteroidal anti-inflammatory drug (NSAID) utilization for musculoskeletal disorders in blue collar workers

British Journal of Clinical Pharmacology

Volumn 67, Issue 1, 2009, Pages 118-124

  Rossignol, Michel ^a,g   Abouelfath, Abdelilah ^b   Lassalle, Regis ^b   Merlière, Yvon ^c   Droz, Cécile ^b   Bégaud, Bernard ^b,d,e   Depont, Fanny ^b   Moride, Yola ^f   Blin, Patrick ^b   Moore, Nicholas ^b,d,e   Fourrier Réglat, Annie ^b,d,e  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c Bioinformatique et Chimie Moléculaire   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

^e INSERM U657   (France)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

^g NONE   (Canada)

Author keywords

Drug utilization; Nonsteroidal anti inflammatory drugs; Occupations; Pharmacoepidemiology

Indexed keywords

ACETYLSALICYLIC ACID; ANTIASTHMATIC AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIULCER AGENT; ANXIOLYTIC AGENT; CYCLOOXYGENASE 2 INHIBITOR; HYPNOTIC SEDATIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; BACKACHE; BLUE COLLAR WORKER; BODY HEIGHT; BODY MASS; BODY WEIGHT; COHORT ANALYSIS; CONFIDENCE INTERVAL; DISEASE SEVERITY; DRUG UTILIZATION; DYSPEPSIA; FEMALE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MUSCLE STRAIN; MUSCULOSKELETAL DISEASE; MYALGIA; OSTEOARTHRITIS; PEPTIC ULCER; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; REIMBURSEMENT; RISK FACTOR; SMOKING;

EID: 58149105540     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03318.x     Document Type: Article

References (20)

1. World Health Organization Scientific Group. The Burden of Musculoskeletal Conditions at the Start of the New Millenium. WHO Technical Report Series 919. Geneva : WHO, 2003, 218 pages. Available at http://whqlibdocint/trs/WHO_TRS_919. pdf (last accessed 8 February 2008).
2. Depont F, Fourrier A, Merliere Y, Droz C, Amouretti M, Begaud B, Benichou J, Moride Y, Blin P, Moore N CADEUS Team. The CADEUS study: methods and logistics. Pharmacoepidemiol Drug Saf 2007 16 : 571 80.
3. Depont F, Fourrier A, Merliere Y, Droz C, Amouretti M, Begaud B, Benichou J, Moride Y, Velo GP, Sturkenboom M, Blin P, Moore N on behalf of the CADEUS team. Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study. Pharmacoepidemiol Drug Saf 2007 16 : 891 900.
4. Fourrier-Réglat A, Droz-Perroteau C, Bénichou J, Depont F, Amouretti M, Bégaud B, Moride Y, Blin P, Moore N, the CADEUS team. Impact of prescriber nonresponse on patient representativeness. Epidemiology 2008 19 : 186 90.
5. Hébert F, Duguay P, Massicotte P, Levy M Revision of Occupational Categories Used in the Surveillance of Occupational Injuries (technical guide R-137). Montréal : Quebec Research Institute in Occupational Health and Safety, 1996, 52 pages (in French).
6. Fautrel B, Hilliquin P, Rozenberg S, Allaert FA, Coste P, Leclerc A, Rossignol M. Impact of osteoarthritis: results of a nationwide survey of 10 000 patients consulting for OA. Joint Bone Spine 2005 72 : 235 40.
7. Mortensen JT, Olesen AV, Boggild H, Olsen J, Westgard-Nielsen NC. Socioeconomic correlates of drug use based on prescription data: a population-based cross-sectional register study in Denmark 1999. Dan Med Bull 2007 54 : 62 6.
8. Czernichow S, Flahault A. Phone prompt or mailed reminder for increasing response rate among investigators? a randomized trial in the Sentinelles network Rev Epidemiol Sante Publique 2001 49 : 93 4 (in French).
9. Harrison RA, Cock D Increasing response to a postal survey of sedentary patients - a randomised controlled trial. BMC Health Serv Res 2004 4 : 31.
10. Kusnik-Joinville O, Weill A, Salanave B, Ricordeau P, Allemand H. Prevalence and treatment of diabetes in France: trends between 2000 and 2005. Diabetes Metab 2008 34 : 266 72.
11. Noize P, Moore N, Lechevallier-Michel N, Fourrier-Réglat A, the 3C Study Group. Comparison of patient interviews and computerized database for determination of drug exposure in pharmacoepidemiology: data from the Three-City (3C) study. Pharmacoepidemiol Drug Saf 2006 15 : S58 9 (abstract).
12. Côté P, van der Velde G, Cassidy JD, Carroll LJ, Hogg-Johnson S, Holm LW, Carragee EJ, Haldeman S, Nordin M, Hurwitz EL, Guzman J, Peloso PM Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. The burden and determinants of neck pain in workers: results of the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. Spine 2008 33 (4 Suppl. S60 74.
13. Denoeud L, Mazières B, Payen-Champenois C, Ravaud P. First line treatment of knee osteoarthritis in outpatients in France: adherence to the EULAR 2000 recommendations and factors influencing adherence. Ann Rheum Dis 2005 64 : 70 4.
14. Bongers PM, Ijmker S, van den Heuvel S, Blatter BM. Epidemiology of work related neck and upper limb problems: psychosocial and personal risk factors (part I) and effective interventions from a bio behavioural perspective (part II). J Occup Rehabil 2006 16 : 279 302.
15. Leroux I, Dionne CE, Bourbonnais R, Brisson C. Prevalence of musculoskeletal activity limitation and associated factors among adults in the general population in the 1998 Quebec Health Survey. J Rheumatol 2005 32 : 1794 804.
16. Rossignol M, Leclerc A, Allaert FA, Rozenberg S, Valat JP, Avouac B, Coste P, Litvak E, Hilliquin P. Primary osteoarthritis of hip, knee and hand in relation to occupational exposure. Occup Environ Med 2005 62 : 772 7.
17. Rossignol M, Leclerc A, Hilliquin P, Allaert FA, Rozenberg S, Valat JP, Avouac B, Coste P, Savarieau B, Fautrel B. Primary osteoarthritis and occupations: a national cross sectional survey of 10 412 symptomatic patients. Occup Environ Med 2003 60 : 882 6.
18. Moride Y, Ducruet T, Boivin JF, Moore N, Perreault S, Zhao S. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study. Arthritis Res Ther 2005 7 : R333 42.
19. Silverstein FE, Raich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS. Gastrointestinal toxicity with celecocib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS study: a randomized controlled trial. JAMA 2000 284 : 1247 55.
20. Poitras S, Avouac J, Rossignol M, Avouac B, Cedraschi C, Nordin M, Rousseaux C, Rozenberg S, Savarieau B, Thoumie P, Valat JP, Vignon E, Hilliquin P. A critical appraisal of guidelines for the management of knee osteoarthritis using Appraisal of Guidelines Research and Evaluation criteria. Arthritis Res Ther 2007 9 : R126.